Christian Erbel

Functional profile of activated dendritic cells in unstable atherosclerotic plaque.

Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.

Beta2-integrin activation on T cell subsets is an independent prognostic factor in unstable angina pectoris.

Return to work after heart transplantation: discrepancy with subjective work ability.

Reversible left ventricular dysfunction resembling Takotsubo syndrome after self-injection of adrenaline.

CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.

Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.

Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels.

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients.

High-sensitive Troponin T measurements early after heart transplantation predict short- and long-term survival.

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation.

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.

Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study.

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation.

CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo.